Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Acta Poloniae Pharmaceutica|February 8, 2006
Enicostemma littorale Blume aqueous extract improves the antioxidant status in alloxan-induced diabetic rat tissuesPonnaian Stanley Mainzen Prince, Mohan Srinivasan
Journal of Molecular Recognition : JMR|April 3, 2008
Conformational flexibility and kinetic complexity in antibody-antigen interactionsKaterina Kourentzi, Mohan Srinivasan, Sandra J Smith-Gill, et al.
Analytical and Bioanalytical Chemistry|January 30, 2020
Mapping binding epitopes of monoclonal antibodies targeting major histocompatibility complex class I chain-related A (MICA) with hydrogen/deuterium exchange and electron-transfer dissociation mass spectrometryRichard Y-C Huang, Michelle Kuhne, Shrikant Deshpande, et al.
Cancer Immunology Research|April 30, 2014
Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cellsMark J Selby, John J Engelhardt, Michael Quigley, et al.
Mabs|November 15, 2017
Hydrogen/deuterium exchange mass spectrometry and computational modeling reveal a discontinuous epitope of an antibody/TL1A InteractionRichard Y-C Huang, Stanley R Krystek, Nathan Felix, et al.
Rapid Communications in Mass Spectrometry : RCM|June 8, 2018
Fucosyl monosialoganglioside: Quantitative analysis of specific potential biomarkers of lung cancer in biological matrices using immunocapture extraction/tandem mass spectrometryAsoka Ranasinghe, John Mehl, Celia D'Arienzo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaquesTibor Keler, Ed Halk, Laura Vitale, et al.
Bioanalysis|May 7, 2013
Novel detection of DNA-alkylated adducts of antibody-drug conjugates with potentially unique preclinical and biomarker applicationsLourdes Thevanayagam, Alasdair Bell, Indrani Chakraborty, et al.
Chembiochem : a European Journal of Chemical Biology|July 8, 2025
Design and Characterization of Prodrugged Anti-CTLA-4 AntibodiesSayumi Yamazoe, Mary Huber, Srikanth Kotapati, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2017
Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumabUdupi A Ramagopal, Weifeng Liu, Sarah C Garrett-Thomson, et al.
Pageof 2